Market Research Logo

World Market for Molecular Diagnostics, 3rd. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)


Attention: There is an updated edition available for this report.

Molecular diagnostics represents a revolution postponed, perhaps, but one that is now clearly underway. DNA Testing has emerged fully from research into clinical practice and becoming a dominant platform in clinical medicine.

From Emerging to Emergent Technology

Instrumentation now automates many of the sample preparation and assay steps that were formerly labor intensive. New tests are being launched all the time. At each step of the way, Kalorama Information has reported on its progress, and in this latest market research report we look at the present state of the market, and the advances that have made DNA testing routine.

Many molecular tests are CE Marked and FDA-cleared and many more are in development. The result is that molecular testing is indicated in many areas of health care.

Molecular Testing Compiled and Analyzed and Explained by a Leading Expert

Authored by lead Kalorama diagnostic analyst Shara Rosen, Kalorama Information's World Market for Molecular Diagnostics is the most comprehensive global market report available on the emergent field of molecular diagnostics.

This report covers key platforms of molecular diagnostics, including the following :

  • Polymerase Chain Reaction (PCR)
  • Non-PCR Amplification Technologies, including:
    • bDNA
    • TMA
    • SDA
    • LIPA
    • NASBA
    • Invader
    • Others
  • In-situ Hybridization
  • Sequencing
  • Microarrays
  • Laser Capture Microdissection (LCM) and Tissue Arrays
  • Mass Spectroscopy
  • Other Molecular Platforms
This report provides market estimates and analysis for molecular diagnostics in the following categories:
  • Infectious Diseases (including HIV, Hepatitis GC/Chlamydia,Organism ID, MRSA, HAI et al, Mycobacteria, TB Respiratory, Others)
  • Blood Screening
  • Histology
  • Oncology
  • Prenatal
  • Coagulation
  • Tissue Typing
  • Inherited Diseases
  • Pharmacodiagnostics
The various clinical techniques and trends are discussed from the point of view of their present and potential market impact.

Market analysis in this report covers world markets for in vitro diagnostics, with focus on the developed areas of the globe -- North America and Western Europe. However public health and infectious disease are a growing global problem and where possible the report covers IVD products related to the globalization of diseases.

As part of its exhaustive coverage of nucleic acid testing, the report includes the following:

  • Market Sizes and Forecasts
  • Profile and Assessment of Over 140 Key Competitors
  • Breakout of Molecular Diagnostic Market by Region (N. America, W. Europe, Asia, ROW)
  • Medical and Technological Trends
  • Discussion of Globalization of Markets and Diseases
  • Information on Reimbursement of New Technologies
  • Review of Novel Test Platforms
  • Review of New Market Developments, Such as Consumer Genomics and Testing Services
  • Discussion of Market Impact of Home Brew Tests
  • Discussion of Diagnostic Biomarkers and Genetic Indicators

All market data are based on factory sales to the end user and not retail pricing or reimbursement payments. Data for the molecular test market are presented in U.S. dollar market size for categories of tests, and for specific analytes where possible. The dollar value of a market segment is directly proportional to the number of tests performed, because the cost of the instrumentation is generally buried in the per test price.

The report discusses tests and technologies that are currently available and those that are expected to take their place. Generally, current products and technologies establish the standard of care and its value to payers. Many of the assays and techniques presented in the report are expected to replace the standard of care in 2007/08, but with healthcare systems' emphasis on cost/benefit analysis for new technologies adoption, the market value and thus penetration capabilities of newer approaches may be limited.

Unsurpassed Breadth of Coverage

The information presented in this report is derived from publicly available information sources such as company, government, and medical organization reports. The analysis is based on the author's industry knowledge combined with literature searches and interviews with industry professionals and experts in the areas of in vitro diagnostics and molecular pathologists. Companies profiled in this study include:
    Top Companies

  • Abbott Diagnostics
  • Becton, Dickinson and Company (BD)
  • Beckman Coulter Inc.
  • bioMerieux Inc.
  • Celera
  • Cepheid
  • Dako A/S
  • Digene Corporation
  • Genomic Health
  • Gen-Probe Inc.
  • Genzyme Corporation
  • Ortho Clinical Diagnostics (OCD)
  • Qiagen N.V.
  • Roche Diagnostics
  • Siemens Medical Solutions Diagnostics
  • Sysmex Corporation
  • Ventana Medical Systems. Inc.

    Other Companies

  • 23andMe, Inc.
  • 454 Life Sciences Corporation
  • AdnaGen AG
  • Adnavance Technologies Inc.
  • Advanced Analytical Technologies, Inc. (AATI)
  • AdvanDx, Inc.
  • Affymetrix
  • Agendia B.V.
  • Agilent Technologies Inc.
  • Almac Diagnostics (formerly ArraDx)
  • Althea Technologies, Inc.
  • Ambry Genetics Corporation
  • Arcxis Biotechnologies
  • Asuragen, Inc.
  • Athena Diagnostics, Inc.
  • Atlas Genetics Limited
  • AutoGenomics, Inc.
  • AviaraDx (formerly Arcturus Biosciences)
  • bcs BIOTECH S.p.A.
  • BG Medicine
  • Biocept, Inc.
  • BioHelix Corporation
  • BioNanomatrix
  • Bio-Reference Laboratories, Inc. (BRLI)
  • Biotage AB (formerly Pyrosequencing Technologies)
  • Biotools, B & M Labs, S.A.
  • BioTrove, Inc.
  • China Medical Technologies, Inc.
  • Clarient Inc. (formerly ChromaVision)
  • Clinical Data, Inc.
  • CLONDIAG chip technologies GmbH
  • CombiMatrix Molecular Diagnostics (CMDX)
  • Consumer Genetics
  • Correlogic Systems, Inc.
  • Curidium Medica Plc
  • deCode Genetics Inc.
  • DiaGenic ASA
  • Diatherix Laboratories Inc.
  • DNAFORM
  • DNA Direct, Inc.
  • The DNA Repair Company (DNAR)
  • DxS Ltd.
  • eGene Inc.
  • eGenomics, Inc.
  • Eiken Chemical Co., Ltd
  • Enigma Diagnostics Limited
  • Epigenomics AG
  • Epistem Ltd.
  • Eppendorf Biochip Systems GmbH
  • EraGen Biosciences Inc.
  • EXACT Sciences Corporation
  • Exiqon A/S
  • Fluidigm Corporation
  • Focus Diagnostics, Inc.
  • Fujifilm Diagnostics (Fujifilm GmbH)
  • Gene Express, Inc.
  • GeneNews Limited
  • GenoID Ltd.
  • Genomas
  • Genoptix, Inc.
  • GENPOINT AS
  • Greiner Bio-One International AG
  • Hain Lifescience GmbH
  • Hamilton Thorne Biosciences, Inc.
  • HandyLab, Inc.
  • Health Discovery Corporation
  • HiFi DNA Tech, LLC
  • Ikonisys Inc.
  • Illumina
  • Immunicon Corporation
  • Innogenetics NV
  • InterGenetics, Inc.
  • Interleukin Genetics, Inc.
  • IntegraGen SA
  • Invitrogen Corporation
  • Ipsogen
  • Iris BioTechnologies Inc.
  • KREATECH Biotechnology B.V.
  • Lab21 Healthcare
  • Laboratory Corporation of America Holdings (LabCorp)
  • Med BioGene, Inc. (MBI)
  • Microchip Biotechnologies, Inc. (MBI)
  • Microgen Bioproducts Ltd.
  • Mobidiag Oy
  • Molzym GmbH & Co. KG
  • Monogram Biosciences, Inc. (formerly ViroLogic)
  • Myconostica, Ltd.
  • Myriad Genetics, Inc.
  • Nanogen
  • Nanosphere, Inc.
  • Navigenics
  • NeuroMark
  • NorDiag ASA
  • Novartis Vaccines and Diagnostics/Chiron
  • Nuvera Biosciences
  • OncoMethylome Sciences S.A.
  • Orchid Cellmark
  • Orion Genomics
  • Osmetech plc
  • Pacific Biosciences of California, Inc. (PacBio)
  • ParagonDx LLC
  • Pathwork Diagnostics (formerly Predicant Biosciences)
  • Perceptronix Medical Inc.
  • PerkinElmer, Inc.
  • Prediction Sciences
  • Prodesse, Inc.
  • Progenika Biopharma
  • Psynomics Incorporated
  • Q Chip Ltd.
  • Quest Diagnostics Incorporated
  • Rosetta Genomics Ltd.
  • Seegene, Inc.
  • SensiGen LLC
  • Sequenom, Inc.
  • SIRS-Lab
  • Smart Genetics
  • Tepnel Life Sciences
  • TessArae, LLC
  • TheraGenetics, Limited
  • Third Wave Technologies Inc.
  • Transgenomic Inc.
  • TrimGen Corporation
  • Veredus Laboratories Pte Ltd.
  • Veridex, LLC
  • Vita Genomics
  • Xceed Molecular
  • XDx Inc.
  • Xenomics, Inc.
  • Zila, Inc.


  • Executive Summary
    • INTRODUCTION
    • SCOPE AND METHODOLOGY
      • Table Exchange Rate Fluctuations, 2003-2007
    • SIZE AND GROWTH OF THE MARKET
      • Changes in Healthcare Delivery
      • Demand for Faster Test Turnaround
      • Large Menu
      • Ease of Use of Systems
      • Multiplex Systems
        • Table Worldwide Molecular Test Sales, 2007-2012 (millions)
        • Table Market Penetration Of Clinical Molecular Diagnostics, by Geographic area (Percent of Molecular Test Sales, 2007-2012)
    • MARKET TRENDS
  • Introduction
    • BACKGROUND
      • Table Selected Events in the Evolution of DNA Testing
    • THE STATUS QUO AND HUGE POTENTIAL OF MOLECULAR DIAGNOSTICS
      • Screening Asymptomatic Populations
    • GENES AND PHARMACOGENOMICS 101
    • POINT OF VIEW
  • Medical Trends And Market Issues
    • BACKGROUND
    • NEW TESTING OPPORTUNITIES - GENES AND PROTEINS
      • Table Selected Platforms for Multiplexed Nucleic Acids and Proteins
    • REIMBURSEMENT OF NOVEL TESTS
      • Medicare and Medicaid
      • HMOs and Managed Care
      • GTE Subscription Based Model
    • COMMERCIALIZING MOLECULAR DIAGNOSTICS
      • Increasing Efficiency
      • Successful Patents
      • Lab-Developed Test Services
    • REGULATORY ISSUES AND MOLECULAR TESTS
    • THE PROMISE OF COMPANION DIAGNOSTICS
      • Table Selected SNP - Drug Interactions
    • FROM RESEARCH TO CLINIC
    • TEST SERVICES
      • Table Selected Molecular Test Services Available in 2008
  • Technological Trends That Enable The Future of Molecular Diagnostics
    • BACKGROUND
    • THE IN VITRO/IN VIVO MIX
    • MINIATURIZATION AND MULTIPLEXED BIOLOGICAL ASSAYS
      • Microfluidic Devices
      • Bead-Based Technologies
        • Table Selected Multiplexed Molecular Assays, 2008 (Company, Location, Details, Status)
    • THE SEARCH FOR NON-INVASIVE TOOLS
      • Table Selected Non-invasive Molecular Tests
      • Saliva
      • Breath
      • Hair
      • Serum
    • MECHANISMS OF GENE MODIFICATION, REGULATION AND EXPRESSION
      • Methylated Gene (meDNA) Patterns
        • Table Selected Methylated DNA Tests
      • RNA - Ribonucleic Acid
        • Table Selected RNA-based Cancer tests
      • Transcription Factors
      • Circulating Cell-free Nucleic Acids
    • SAMPLE PREPARATION AND SYSTEM AUTOMATION
      • Homebrew Reagents
      • DNA Test Sample Preparation Market
        • Table Selected Nucleic Acid Sample Preparation Products
    • PCR PATENT UPDATE
  • Platforms At The Forefront Of Molecular Assays
    • BACKGROUND
      • Components of DNA tests
    • MOLECULAR TEST PLATFORMS MARKET OVERVIEW
      • Table Market Potential Of Key Clinical Molecular Platforms, 2008 (Established or Emerging, High, Medium or Weak Potential)
      • Table Molecular Test Product Sales, Worldwide, by Platform, 2007 (PCR, Non PCR Amplification, In Situ Hybridization, Sequencing, Microarrays, Tissue Arrays, Mass Spectroscopy, Others)
      • Polymerase Chain Reaction (PCR)
        • Table Selected Companies With PCR-Based Products
      • Non-PCR Amplification Technologies
        • Table Non-PCR Molecular Tests Sales, Worldwide, by Platform, 2007 (bDNA, TMA, SDA, LIPA, NASBA, Invader, Others) ($ Millions)
        • Table Selected Non-PCR Molecular Platforms
        • Table Selected New Molecular Test Platforms
      • Miniaturized Platforms - Arrays and Biochips
        • Table Major Microfluidics Companies
      • Mass Spectroscopy
        • Table Major Molecular Markers For Tissue Staining
        • Table Selected In Situ Hybridization Innovation
      • Laser Capture Microdissection (LCM) and Tissue Arrays
        • Table Selected LCM Systems on the Market, 2008
      • TMAs
  • Market Analysis
    • Table Worldwide Molecular Test Sales, 2007-2012 (Infectious Disease, Blood Screening, Histology, Oncology, Prenatal, Coagulation, Tissue Typing, Inherited Diseases, Pharmacodiagnostics), Sample Prep Market and PCR Probe Reagents (Sales $ millions)
    • Table Breakdown Of Home-Brew Molecular Diagnostic Tests, 2007
    • WORLDWIDE OPPORTUNITIES FOR MOLECULAR TESTS
      • Table Market Penetration Of Clinical Molecular Diagnostics, by geographic area (North America, W. Europe, Japan, ROW) (Percent of Molecular Test Sales, 2007-2012)
    • THE UNITED STATES
    • EUROPE
    • CHINA
    • MOLECULAR DIAGNOSTICS ANDTARGET MARKETS
      • Table Average Cost Of Selected Genetic Test Services, US
      • Table Selected Reference Lab and IVD Company Collaborations
    • THE MARKET FOR MOLECULAR ASSAYS IN CANCER MANAGEMENT
      • CUP/TUO
      • Herceptin
        • Table Selected IVD Cancer Markers used in Tissue Analysis
    • THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY
      • Towards Routine Hematology Testing
    • THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION
      • Procoagulation and Thrmobolytic Markers
      • Warfarin
        • Table Selected Molecular Tests for Coagulation Testing (Company, Location, Area, Details, Status)
    • THE MARKET FOR MOLECULAR ASSAYS IN HISTOPATHOLOGY/CYTOLOGY
      • Overview
      • The Future of the Pap Smear & HPV Testing
        • Table Selected Advanced HPV Tests, 2006-2008 (Company, Location, Test, Status)
      • In Situ Hybridization and Digital Cytometry
      • Microscopy
        • Table Selected Microscopy and Image Analysis Product Companies
    • THE MARKET FOR MOLECULAR ASSAYS IN MICROBIOLOGY/VIROLOGY
      • Table Molecular Test Sales, Infectious Diseases (HIV, Hepatitis, GC/Chlamydia, Organism ID/MRSA et al, Mycobacteria/TB, Respiratory, Others) , 2007-2012 ($ Millions)
      • HIV
      • STDs
      • Hospital Acquired Infections (HAIs)
      • Respiratory Viruses
        • Table Selected Infectious Disease Molecular Test Products, 2006-2008 Company, Location, Details, Status)
    • THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION MEDICINE
      • Transfusion Statistics
      • Trends in Transfusion Medicine
      • Blood Screening Markets
      • PROCLEIX
        • Table Selected Molecular Test Innovations in Blood Transfusion Medicine
    • THE MARKET FOR MOLECULAR ASSAYS IN TISSUE TRANSPLANT MANAGEMENT
    • MOLECULAR ASSAYS IN PRENATAL AND NEONATAL TESTING
      • Prental Carrier and Fetus Screening Market
      • FISH Assays
      • PAP Assay
      • IVF Fertilization Procedure Testing
    • THE MARKET FOR MOLECULAR ASSAYS FOR INHERITED DISEASES
      • Table Most Frequently Requested Genetic Tests
      • Table Selected Molecular Tests for Inherited Diseases
    • PHARMACODIAGNOSTIC TEST APPLICATIONS
  • Major Vendors and Companies To Watch
    • Table Molecular Test Revenues of Selected IVD Vendors, 2005-2007
    • COMPANY TRIAGE
    • THE MAJORS
    • THE STARS
    • PARTICIPANTS
    • NEWCOMERS
    • 2012 AND BEYOND
      • Table Selected Molecular Test Innovations, 2007/08
      • Acquisitions, Alliances and Collaborations in Molecular Diagnostics
        • Table Selected Acquisitions and Collaborations, 2006-2008
        • Table Distribution and Licensing Agreements (Comp., Location, Details)
  • Conclusions and Strategic Implications
    • CONCLUSION ONE
      • Implication
    • CONCLUSION TWO
      • Implication
    • CONCLUSION THREE
      • Implication
    • CONCLUSION FOUR
      • Implication
    • CONCLUSION FIVE
      • Implication
    • CONCLUSION SIX
      • Implication
  • Company Profiles: The Top Tier
    • ABBOTT DIAGNOSTICS
      • Table Kalorama's estimated breakdown of Abbott's revenue in selected test segments ($ million)
      • Key Comment
      • Details
    • BECTON, DICKINSON AND COMPANY (BD)
      • Table Breakdown of BD's IVD products revenue in selected test segments (in millions)
      • Key Comment
      • Details
    • BECKMAN COULTER INC.
      • Table Breakdown of Beckman Coulter's revenue in selected test segments ($ million)
      • Key Comment
      • Details
    • BIOMERIEUX INC.
      • Table Breakdown of bioMérieux's IVD product revenue in selected test segments
      • Key Comment
      • Details
    • CELERA
      • Table The Abbott Celera alliance generated product sales of:
      • Key Comment
      • Details
    • CEPHEID
      • Table Recent Revenue History: ($ million, clinical product sales)
      • Key Comment
      • Details
    • DAKO A/S
      • Table Recent Revenue History: Pathology product sales
      • Key Comment
      • Details
    • DIGENE CORPORATION
      • Table Recent Revenue History:
      • Key Comment
      • Details
    • GENOMIC HEALTH
      • Table Recent Revenue History
      • Key Comment
      • Details
    • GEN-PROBE INC.
      • Table Recent Revenue History: ($ million)
      • Key Comment
      • Details
    • GENZYME CORPORATION
      • Table Recent Revenue History: diagnostics/genetics tests and services
      • Key Comment
      • Details
    • ORTHO CLINICAL DIAGNOSTICS (OCD)
      • Table Recent Revenue History: (in millions)
      • Table Breakdown of OCD's revenue in selected test segments in 2007
      • Key Comment
    • QIAGEN N.V.
      • Table Recent Revenue History: ($ million)
      • Key Comment
      • Details
    • ROCHE DIAGNOSTICS
      • Table Recent Revenue History (in millions)
      • Table Breakdown of Roche's revenue in selected test segments (in millions)
      • Key Comment
      • Details
    • SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS
      • Table Recent Revenue History: (estimated by Kalorama, $ million)
      • Table Kalorama's estimated breakdown of Siemens' IVD product sales in selected test segments, 2007 ($ million)
      • Key Comment
      • Details
    • SYSMEX CORPORATION
      • Table Recent Revenue History: ($ million)
      • Table Kalorama's estimated breakdown of Sysmex's 2007 product sales in selected test segments (million)
      • Key Comment
      • Details
    • VENTANA MEDICAL SYSTEMS. INC.
      • Table Recent Revenue History: $ million
      • Key Comment
      • Details
  • Company Profiles: The Second Tier
    • 23ANDME, INC.
      • Details
    • 454 LIFE SCIENCES CORPORATION
      • Details
    • ADNAGEN AG
      • Key Comment
      • Details
    • ADNAVANCE TECHNOLOGIES INC.
      • Key Comment
      • Details
    • ADVANCED ANALYTICAL TECHNOLOGIES, INC. (AATI)
      • Key Comment
      • Details
    • ADVANDX, INC.
      • Key Comment
      • Details
    • AFFYMETRIX
      • Table Recent Revenue History: ($ million)
      • Details
    • AGENDIA BV
      • Key Comment
      • Details
    • AGILENT TECHNOLOGIES INC.
      • Details
    • ALMAC DIAGNOSTICS (FORMERLY ARRADX)
      • Key Comment
      • Details
    • ALTHEA TECHNOLOGIES, INC.
      • Key Comment
      • Details
    • AMBRY GENETICS CORPORATION
      • Key Comment
      • Details
    • ARCXIS BIOTECHNOLOGIES
      • Key Comment
      • Details
    • ASURAGEN, INC.
      • Key Comment
      • Details
    • ATHENA DIAGNOSTICS, INC.
      • Key Comment
      • Details
    • ATLAS GENETICS LIMITED
      • Details
    • AUTOGENOMICS, INC.
      • Key Comment
      • Details
    • AVIARADX (FORMERLY ARCTURUS BIOSCIENCES)
      • Details
      • Key Comment
    • BCS BIOTECH S.P.A.
      • Key Comment
      • Details
    • BG MEDICINE
      • Key Comment
      • Details
    • BIOCEPT, INC.
      • Key Comment
      • Details
    • BIOHELIX CORPORATION
      • Key Comment
      • Details
    • BIONANOMATRIX
      • Key Comment
      • Details
    • BIO-REFERENCE LABORATORIES, INC. (BRLI)
      • Key Comment
      • Details
    • BIOTAGE AB (FORMERLY PYROSEQUENCING TECHNOLOGIES)
      • Table Recent Revenue History
      • Key Comment
      • Details
    • BIOTOOLS, B & M LABS, SA
      • Key Comment
        • Table Biotools has a very low footprint in a highly competitive business
      • Details
    • BIOTROVE, INC.
      • Key Comment
    • CHINA MEDICAL TECHNOLOGIES, INC.
      • Table Recent Revenue History: ($ million)
      • Details
    • CLARIENT INC. (FORMERLY CHROMAVISION)
      • Table Recent Revenue History: New Clarient - service component
      • Details
    • CLINICAL DATA, INC.
      • Key Comment
      • Details
    • CLONDIAG CHIP TECHNOLOGIES GMBH
      • Key Comment
      • Details
    • COMBIMATRIX MOLECULAR DIAGNOSTICS (CMDX)
      • Table Recent Revenue History (est):
      • Key Comment
      • Details
    • CONSUMER GENETICS
      • Key Comment
    • CORRELOGIC SYSTEMS, INC.
      • Key Comment
      • Details
    • CURIDIUM MEDICA PLC
      • Key Comment
      • Details
    • DECODE GENETICS INC.
      • Table Recent Revenue History: service and research revenues
      • Key Comment
      • Details
    • DERMTECH INTERNATIONAL
      • Key Comment
      • Details
    • DIAGENIC ASA
      • Key Comment
      • Details
    • DIATHERIX LABORATORIES INC.
      • Key Comment
      • Details
    • DNAFORM
      • Key Comment
      • Details
    • DNA DIRECT, INC.
      • Key Comment
      • Details
    • THE DNA REPAIR COMPANY (DNAR)
      • Key Comment
      • Details
    • DXS LTD.
      • Key Comment
      • Details
    • EGENE INC.
      • Table Recent Revenue History
      • Key Comment
      • Details
    • EGENOMICS, INC.
      • Key Comment
      • Details
    • EIKEN CHEMICAL CO., LTD
      • Table Recent Revenue History: not all clinical diagnostics
      • Key Comment
      • Details
    • ENIGMA DIAGNOSTICS LIMITED
      • Key Comment
      • Details
    • EPIGENOMICS AG
      • Key Comment
      • Details
    • EPISTEM LTD.
      • Key Comment
      • Details
    • EPPENDORF BIOCHIP SYSTEMS GMBH
      • Key Comment
      • Details
    • ERAGEN BIOSCIENCES INC.
      • Key Comment
      • Details
    • EXACT SCIENCES CORPORATION
      • Key Comment
      • Details
    • EXIQON A/S
      • Table Recent Revenue History:
      • Key Comment
      • Details
    • FLUIDIGM CORPORATION
      • Details
    • FOCUS DIAGNOSTICS, INC.
      • Key Comment
      • Details
    • FUJIFILM DIAGNOSTICS (FUJIFILM GMBH)
      • Key Comment
      • Details
    • GENE EXPRESS, INC.
      • Key Comment
      • Details
    • GENENEWS LIMITED
      • Key Comment
      • Details
    • GENEKAM BIOTECHNOLOGY AG
      • Key Comment
      • Details
    • GENELEX CORPORATION
      • Key Comment
      • Details
    • GENOID LTD.
      • Key Comment
      • Details
    • GENOMAS
      • Key Comment
    • GENOPTIX, INC.
      • Table Recent Revenue History:
      • Key Comment
      • Details
    • GENPOINT AS
      • Key Comment
      • Details
    • GREINER BIO-ONE INTERNATIONAL AG
      • Table Recent Revenue History:
      • Key Comment
      • Details
    • HAIN LIFESCIENCE GMBH
      • Key Comment
      • Details
    • HAMILTON THORNE BIOSCIENCES, INC.
      • Key Comment
      • Details
    • HANDYLAB, INC.
      • Key Comment
      • Details
    • HEALTH DISCOVERY CORPORATION
      • Key Comment
      • Details
    • HIFI DNA TECH, LLC
      • Key Comment
      • Details
    • IKONISYS INC.
      • Key Comment
      • Details
    • ILLUMINA
      • Key Comment
      • Details
    • IMMUNICON CORPORATION
      • Table Recent Revenue History: Immunicon went public early 2004 and has begun shipping its CellSpotter system and reagents as of August 2004.
      • Key Comment
      • Details
    • INNOGENETICS NV
      • Table Recent Revenue History: (in millions)
      • Key Comment
      • Details
    • INTERGENETICS, INC.
      • Key Comment
      • Details
    • INTERLEUKIN GENETICS, INC.
      • Table Recent Revenue History
      • Key Comment
      • Details
    • INTEGRAGEN SA
      • Key Comment
      • Details
    • INVITROGEN CORPORATION
      • Key Comment
      • Details
    • IPSOGEN
      • Key Comment
    • IRIS BIOTECHNOLOGIES INC.
      • Key Comment
      • Details
    • KREATECH BIOTECHNOLOGY B.V.
      • Key Comment
      • Details
    • LAB21 HEALTHCARE
      • Key Comment
      • Details
    • LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
      • Table Recent Revenue History:
      • Key Comment
      • Details
    • LUMINEX CORPORATION
      • Table Recent Revenue History:
      • Table Luminex Medical Diagnostics (Tm Bio) - $ million
      • Key Comment
      • Details
    • MED BIOGENE, INC. (MBI)
      • Key Comment
      • Details
    • MICROCHIP BIOTECHNOLOGIES, INC. (MBI)
      • Key Comment
      • Details
    • MICROGEN BIOPRODUCTS LTD.
      • Key Comment
      • Details
    • MOBIDIAG OY
      • Key Comment
      • Details
    • MOLZYM GMBH & CO. KG
      • Key Comment
      • Details
    • MONOGRAM BIOSCIENCES, INC. (FORMERLY VIROLOGIC)
      • Table Recent Revenue History: Product Service Revenue
      • Key Comment
      • Details
    • MYCONOSTICA, LTD.
      • Key Comment
      • Details
    • MYRIAD GENETICS, INC.
      • Table Recent Revenue History
      • Key Comment
      • Details
    • NANOGEN
      • Table Recent Revenue History: ($ million)
      • Key Comment
      • Details
    • NANOSPHERE, INC.
      • Table Recent Revenue History: product sales
      • Key Comment
      • Details
    • NAVIGENICS
      • Key Comment
      • Details
    • NEUROMARK
      • Key Comment
      • Details
    • NORDIAG ASA
      • Table Recent Revenue History
      • Key Comment
      • Details
    • NOVARTIS VACCINES AND DIAGNOSTICS/CHIRON
      • Table Recent Revenue History
      • Key Comment
      • Details
    • NUVERA BIOSCIENCES
      • Key Comment
      • Details
    • ONCOMETHYLOME SCIENCES S.A.
      • Key Comment
      • Details
    • ORCHID CELLMARK
      • Table Recent Revenue History
      • Key Comment
      • Details
    • ORION GENOMICS
      • Key Comment
      • Details
    • OSMETECH PLC
      • Key Comment
      • Details
    • PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACBIO)
      • Key Comment
      • Details
    • PARAGONDX LLC (formerly Gentris Diagnostics Inc.)
      • Key Comment
      • Details
    • PATHWAY DIAGNOSTICS CORPORATION
      • Key Comment
      • Details
    • PATHWORK DIAGNOSTICS (formerly Predicant Biosciences)
      • Key Comment
      • Details
    • PERCEPTRONIX MEDICAL INC.
      • Key Comment
      • Details
    • PERKIN ELMER, INC.
      • Key Comment
      • Details
    • PREDICTION SCIENCES
      • Key Comment
      • Details
    • PRODESSE, INC.
      • Key Comment
      • Details
    • PROGENIKA BIOPHARMA
      • Key Comment
      • Details
    • PSYNOMICS INCORPORATED
      • Key Comment
      • Details
    • Q CHIP LTD.
    • QUEST DIAGNOSTICS INCORPORATED
      • Table Recent Revenue History
      • Details
    • ROSETTA GENOMICS LTD.
      • Key Comment
      • Details
    • SEEGENE, INC.
      • Key Comment
      • Details
    • SENSIGEN LLC
      • Key Comment
    • SEQUENOM, INC.
      • Table Recent Revenue History:
      • Key Comment
      • Details
    • SIRS-LAB
      • Details
    • SMART GENETICS
      • Key Comment
      • Details
    • TEPNEL LIFE SCIENCES
      • Table Recent Revenue History:molecular diagnostics products
      • Key Comment
      • Details
    • TESSARAE, LLC
      • Key Comment
      • Details
    • THERAGENETICS, LIMITED
      • Key Comment
      • Details
    • THIRD WAVE TECHNOLOGIES INC.
      • Table Recent Revenue History:($ million)
      • Key Comment
      • Details
    • TRANSGENOMIC INC.
      • Table Recent Revenue History:
      • Key Comment
    • TRIMGEN CORPORATION
      • Key Comment
      • Details
    • VEREDUS LABORATORIES PTE LTD.
      • Key Comment
      • Details
    • VERIDEX, LLC
      • Key Comment
      • Details
    • VITA GENOMICS
      • Key Comment
      • Details
    • XCEED MOLECULAR (FORMERLY METRIGENIX CORPORATION)
      • Key Comment
      • Details
    • XDX INC.
      • Key Comment
      • Details
    • XENOMICS, INC.
      • Key Comment
      • Details
    • ZILA, INC.
      • Table Recent Revenue History: ViziLite product launched in 2006
      • Key Comment

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report